유방질환에 대한 적절한 접근방법

키워드

참고문헌 (68)

1. Venta LA, "Sonographic evaluation of the breast", Radiographics, 14, pp.29~50 (1994)
2. Boyd NF, "Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy", Lancet, 2, pp.128~132 (1988)
3. Fentiman IS, "Double-blind controlled trial of tamoxifen therapy for mastalgia", Lancet, 1, pp.287~288 (1986)
4. Gateley CA, "Management of cyclical breast pain", Br J Hosp Med, 43, pp.330~332 (1990)
5. Conry C, "Evaluation of a breast complaint: is it cancer", Am Fam Physician, 49, pp.445~454 (1994)
6. Chaudary MA, "The diagnostic value of testing for occult blood", Ann Surg, 196, pp.651~655 (1982)
7. Pruthi S, "Detection and evaluation of a palpable breast mass", Mayo Clin Proc, 76, pp.641~647 (2001)
8. Lucas JH, "Breast cyst aspiration", Am Fam Physician, 68, pp.1983~1986 (2003)
9. Morrow M, "The evaluation of common breast problems", Am Fam Physician, 61, pp.2371~2385 (2000)
10. "Is ‘fi brocystic disease’ of the breast precancerous", Arch Pathol Lab Med, 110, pp.171~173 (1986)
11. Berg WA, "Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer", Radiology, 233, pp.830~849 (2004)
12. Berg WA, "Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666", AJR Am J Roentgenol, 180, pp.1225~1228 (2003)
13. Gordon PB, "Ultrasound for breast cancer screening and staging", Radiol Clin North Am, 40, pp.431~441 (2002)
14. Gordon PB, "Malignant breast masses detected only by ultrasound. A retrospective review", Cancer, 76, pp.626~630 (1995)
15. Yoo KY, "Lifestyle, genetic susceptibility and future trends of breast cancer in Korea", Asian Pac J Cancer Prev, 7, pp.679~682 (2006)
16. Keun-YoungYoo, "Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention", Journal of Korean Medical Science, 17(1), pp.1~6 (2002), 대한의학회
17. Yoo KY, "Is breast cancer incidence rate further increasing in Korea", Korean J Epidemiol, 23, pp.1~7 (2001)
18. Potten CS, "The effect of age and menstrual cycle upon proliferative activity of the normal human breast", Br J Cancer, 58, pp.163~170 (1988)
19. Henderson BE, "Do regular ovulatory cycles increase breast cancer risk", Cancer, 56, pp.1206~1208 (1985)
20. Kelsey JL, "Epidemiology and prevention of breast cancer", Annu Rev Public Health, 17, pp.47~67 (1996)
21. Hunter DJ, "Non-dietary factors as risk factors for breast cancer, and as effect modifi ers of the association of fat intake and risk of breast cancer", Cancer Causes Control, 8, pp.49~56 (1997)
22. "Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer", Lancet, 350, pp.1047~1059 (1997), Collaborative Group on Hormonal Factors in Breast Cancer
23. Petridou E, "Tobacco smoking, pregnancy estrogens, and birth weight", Epidemiology, 1, pp.247~250 (1990)
24. de Waard F, "A unifying concept of the aetiology of breast cancer", Int J Cancer, 41, pp.666~669 (1988)
25. Henderson BE, "Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture", Cancer Res, 48, pp.246~253 (1988)
26. Ota DM, "Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients", Cancer, 57, pp.558~562 (1986)
27. Koch OR, "Oxidative stress and antioxidant defenses in ethanolinduced cell injury", Mol Aspects Med, 25, pp.191~198 (2004)
28. 손병호, "한국인 유전성 유방암", Journal of Breast Cancer, 11(1), pp.1~9 (2008), 한국암학회
29. Sue Kyung Park, "The Estimation of Breast Cancer Disease-Probability by Difference of Individual Susceptibility", Cancer Research and Treatment, 35(1), pp.35~51 (2003), 대한암학회
30. 김성원, "한국인 유전성 유방암 연구 계획서", Journal of Breast Cancer, 10(4), pp.241~247 (2007), 한국유방암학회
31. Lee SY, "Effect of lifetime lactation on breast cancer risk: a Korean women’s cohort study", Int J Cancer, 105, pp.390~393 (2003)
32. Do MH, "Intake of fruits, vegetables, and soy foods in relation to breast cancer risk in Korean women: a case-control study", Nutr Cancer, 57, pp.20~27 (2007)
33. Hong SA, "A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women", Int J Cancer, 122, pp.919~923 (2008)
34. Xue F, "Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence", Lancet Oncol, 8, pp.1088~1100 (2007)
35. Schernhammer ES, "In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor", Cancer Causes Control, 13, pp.505~508 (2002)
36. Michels KB, "Role of birthweight in the etiology of breast cancer", Int J Cancer, 119, pp.2007~2025 (2006)
37. Jung A, "Are children of older fathers at risk for genetic disorders", Andrologia, 35, pp.191~199 (2003)
38. Glaser RL, "Dear old dad", Sci Aging Knowledge Environ, ~ (2004)
39. Ekbom A, "Intrauterine environment and breast cancer risk in women: a population-based study", J Natl Cancer Inst, 89, pp.71~76 (1997)
40. Hubinette A, "Cnattingius S. Birth characteristics and breast cancer risk: a study among likesexed twins", Int J Cancer, 91, pp.248~251 (2001)
41. Casey PM, "Oral contraceptive use and risk of breast cancer", Mayo Clin Proc, 83, pp.86~90 (2008)
42. Brohet RM, "Oral contraceptives and breast cancer risk in the international BRCA1", 2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group, 2007, pp.25, 3831~3836
43. Rossouw JE, "Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
44. Middleton LP, "Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features", Cancer, 98, pp.1055~1060 (2003)
45. Ring AE, "Breast cancer and pregnancy", Ann Oncol, 16, pp.1855~1860 (2005)
46. Sharp C, "Diagnostic medical exposures: advice on exposure to ionizing radiation during pregnancy" (1998), National Radiological Protection Board
47. Jernstrom HC, "Reproductive factors in hereditary breast cancer", Breast Cancer Res Treat, 58, pp.295~301 (1999)
48. Kroman N, "Should women be advised against pregnancy after breastcancer treatment", Lancet, 350, pp.319~322 (1997)
49. Ives A, "Pregnancy after breast cancer: population based study", BMJ, 334, pp.194~ (2007)
50. Oktay K, "Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation", J Clin Oncol, 23, pp.4347~4353 (2005)
51. Neven P, "Van Belle Y. Tamoxifen-induced endometrial polyp", N Engl J Med, 336, pp.1389~ (1997)
52. "Polychemotherapy for early breast cancer: an overview of the randomised trials", Lancet, 352, pp.930~942 (1998), Early Breast Cancer Trialists’ Collaborative Group
53. Howell A, "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer", Lancet, 365, pp.60~62 (2005)
54. Jakesz R, "Switching of postmenopausal women with endocrineresponsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial", Lancet, 366, pp.455~462 (2005)
55. Coombes RC, "A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer", N Engl J Med, 350, pp.1081~1092 (2004)
56. Goss PE, "A randomized trial of letrozole in postmenopausal women after fi ve years of tamoxifen therapy for early-stage breast cancer", N Engl J Med, 349, pp.1793~1802 (2003)
57. Baum M, "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial", Lancet, 359, pp.2131~2139 (2002)
58. Kangas L, "Agonistic and antagonistic effects of antiestrogens in different target organs", Acta Oncol, 31, pp.143~146 (1992)
59. Garuti G, "Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women", Gynecol Oncol, 98, pp.63~67 (2005)
60. Vosse M, "Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring", Eur J Obstet Gynecol Reprod Biol, 101, pp.58~63 (2002)
61. Fisher B, "Endometrial cancer in tamoxifen-treated breast cancer patients: fi ndings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14", J Natl Cancer Inst, 86, pp.527~537 (1994)
62. Lingeman CH, "Etiology of cancer of the human ovary: a review", J Natl Cancer Inst, 53, pp.1603~1618 (1974)
63. Demopoulos RI, "Secondary ovarian carcinoma: a clinical and pathological evaluation", Int J Gynecol Pathol, 6, pp.166~175 (1987)
64. Moore RG, "Incidence of metastasis to the ovaries from nongenital tract primary tumors", Gynecol Oncol, 93, pp.87~91 (2004)
65. Hann LE, "Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation", Radiology, 216, pp.242~247 (2000)
66. Dixon MJ, "Diseases of the breast. 2nd ed", pp.48~ (2000), Lippincott Williams and Wilkins
67. Klein S, "Evaluation of palpable breast masses", Am Fam Physician, 71, pp.1731~1738 (2005)
68. Beral V, "Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study", Lancet, 362, pp.419~427 (2003)

관련 논문AI추천